These include covering medical expenses associated with gallbladder treatment, reimbursement for income lost due to recovery time, and damages for pain and emotional suffering
[DOI] [PubMed] [Google Scholar] 67.Krahenbuhl S., Reichen J
They did this alongside investigating GLP-2
[DOI] [Google Scholar] Annern G, Gebre-Medhin M, Gustavson KH
There is no clear evidence that SCFAs can affect esophageal barrier function, but production of SCFAs in the colon is completely and rapidly absorbed by colonic cells and circulates systemically through the portal vein (95)
Yet, they are marketed under two completely different names, packaged in different boxes, and subjected to entirely different pharmacy benefits and insurance coverages